Obesity and obesity-related dyslipidaemia are major contributors to global cardiometabolic risk. Polyphenol-rich functional foods have gained attention as supportive strategies for the regulation of lipid metabolism and adipose tissue function. Among these, Aronia melanocarpa (black chokeberry) is a rich source of anthocyanins and other bioactive polyphenols with potent antioxidant and metabolic properties. This review evaluates current experimental and clinical evidence on the effects of Aronia melanocarpa on obesity and lipid metabolism. Available data indicate that chokeberry polyphenols may improve lipid homeostasis by modulating adipogenesis, regulating key metabolic pathways, reducing oxidative stress and inflammation, and influencing gut microbiota. However, clinical findings remain heterogeneous due to variations in study design, dosage, and phytochemical composition, as well as the limited bioavailability of anthocyanins. Overall, Aronia melanocarpa appears to be a promising natural agent for the management of obesity and dyslipidaemia, however, further well-designed clinical studies using standardized preparations are required to confirm its therapeutic potential.
Ünal et al. (Mon,) studied this question.